Conduit Pharmaceuticals (CDT) announces that, following confirmation of compliance with the Bid Price and Equity Requirements as detailed in the announcement dated May 21, the Company received formal notice from The Nasdaq Stock Market that the Company’s application to transfer the listing of its common stock to The Nasdaq Capital Market has been approved and the Company’s securities will be transferred to The Nasdaq Capital Market at the opening of business on May 23.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDT: